newsfilter
← Latest News
Business Wire·

GlycoMimetics Stockholders Approve Proposed Merger with Crescent Biopharma and All Related Proposals

—GlycoMimetics Board of Directors approves 1-for-100 reverse stock split— GlycoMimetics, Inc. (NASDAQ:GLYC) ("GlycoMimetics") today announced that its stockholders have approved the proposed merger (the "Merger") with